As mRNA programmes scale in complexity and regulatory scrutiny, teams are under pressure to deliver faster and more robust development. While AI and automation are widely discussed, many organisations still struggle to translate these capabilities into practical, connected workflows that materially improve how work gets done across development and CMC.

Led by Pfizer and BioNTech, this workshop will explore how augmented intelligence and automation can be operationalised, enabling more efficient process development, stronger CMC alignment, and improved regulatory readiness. Attendees will gain insight into where AI and automation deliver immediate value, and how digitally enabled workflows can reduce friction while preserving quality and compliance.

Key Questions to be Addressed:

• Where can AI and automation deliver the greatest operational impact across mRNA analytical development, QC, and CMC workflows?
• How can digital intelligence be connected with laboratory systems such as LIMS, sample workflows, and robotics to create more integrated development environments?
• What practical steps can mRNA teams take today to redesign workflows and prepare their organisations for the next generation of mRNA therapies?

BRAND NEW: Build, Train & Test Your Own mRNA AI System

Work through real mRNA development scenarios to design and build your own AI agenda capable of supporting scientific workflows, analysing information, and completing operational tasks.

*Laptops required to participate